Protagonist Therapeutics, Inc. (PTGX)
105.90
+7.87
(+8.03%)
USD |
NASDAQ |
Jun 09, 16:00
105.90
0.00 (0.00%)
After-Hours: 18:03
Protagonist Therapeutics SG&A Expense (Quarterly) : 13.28M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| AbbVie, Inc. | 3.578B |
| Insmed, Inc. | 247.26M |
| Johnson & Johnson | 6.034B |
| Madrigal Pharmaceuticals, Inc. | 268.52M |
| PTC Therapeutics, Inc. | 86.18M |